We are live on ! Find out more
DMKJ

David M. Knott Jr Portfolio holdings

AUM $189M Turnover 22.11%
1-Year Est. Return 67.72%
This Fund
S&P 500
This Quarter Est. Return
+15.71%
1 Year Est. Return
+67.72%
3 Year Est. Return
+169.37%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$254M
AUM Growth
-$10.2M
Cap. Flow
-$10.1M
Cap. Flow %
-3.98%
Top 10 Hldgs %
65.68%
Holding
185
New
12
Increased
13
Reduced
21
Closed
36
Avg Time Held
0.9 years
Top 10 Avg Time Held
1 year
Top 20 Avg Time Held
0.8 years

Top Buys

Rank Stock Value
1
GCVRZ
Sanofi Contingent Value Rights
GCVRZ
+$3.05M
2
CLMT icon
Calumet Specialty Products
CLMT
+$2.42M
3
WHWK icon
Whitehawk Therapeutics
WHWK
+$1.67M
4
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$1.63M
5
ISEE
IVERIC bio, Inc. Common Stock
ISEE
+$1.42M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$3.55M
2
KW icon
Kennedy-Wilson Holdings
KW
+$2.75M
3
MRK icon
Merck
MRK
+$2.72M
4
SNY icon
Sanofi
SNY
+$2.71M
5
VKTX icon
Viking Therapeutics
VKTX
+$1.87M

Sector Composition

Rank Sector Weight
1 Materials 32.71%
2 Healthcare 28.85%
3 Financials 10.2%
4 Miscellaneous 8.83%
5 Industrials 6.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
CLMT icon
1
Calumet Specialty Products
CLMT
$5.06B
$79.5M 31.25%
4,576,000
+136,000
+3% +$2.42M
2021 Q4
5 quarters
APO icon
2
Apollo Global Management
APO
$67B
$14.2M 5.58%
225,000
– –
2021 Q4
5 quarters
DCGO icon
3
DocGo
DCGO
$26.9M
$12.1M 4.76%
1,400,000
– –
2021 Q4
5 quarters
FTAI icon
4
FTAI Aviation
FTAI
$16.8B
$11.9M 4.67%
425,000
– –
2021 Q4
5 quarters
GOOG icon
5
Alphabet (Google) Class C
GOOG
$4.2T
$11.7M 4.59%
112,220
– –
2021 Q4
5 quarters
FBRT icon
6
Franklin BSP Realty Trust
FBRT
$500M
$10.2M 4.03%
859,047
– –
2021 Q4
5 quarters
LGND icon
7
Ligand Pharmaceuticals
LGND
$5.88B
$8.46M 3.32%
115,000
– –
2021 Q4
5 quarters
ARDX icon
8
Ardelyx
ARDX
$824M
$7.18M 2.82%
1,500,000
– –
2022 Q3
2 quarters
MDWT
9
DELISTED
Midwest Holding Inc. Common Stock
MDWT
$6.17M 2.42%
390,241
– –
2021 Q4
5 quarters
MITAW icon
10
DELISTED
Coliseum Acquisition Corp. Warrant
MITAW
$5.69M 2.24%
495,000
– –
2021 Q4
5 quarters
AGAC.WS
11
DELISTED
African Gold Acquisition Corp Warrants
AGAC.WS
$5.18M 2.04%
450,750
– –
2021 Q4
5 quarters
HZNP
12
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$4.53M 1.78%
41,490
+1,000
+2% +$111K
2021 Q4
5 quarters
OABI icon
13
OmniAb
OABI
$662M
$4M 1.57%
1,086,505
-184,434
-15% -$696K
2022 Q4
1 quarter
PFE icon
14
Pfizer
PFE
$166B
$3.98M 1.56%
97,537
+3,037
+3% +$131K
2021 Q4
5 quarters
MDGL icon
15
Madrigal Pharmaceuticals
MDGL
$10.6B
$3.39M 1.33%
14,000
+6,000
+75% +$1.63M
2022 Q3
2 quarters
VKTX icon
16
Viking Therapeutics
VKTX
$3.24B
$3.33M 1.31%
200,164
-181,457
-48% -$1.87M
2021 Q4
5 quarters
JAZZ icon
17
Jazz Pharmaceuticals
JAZZ
$13.6B
$3.28M 1.29%
22,411
– –
2021 Q4
5 quarters
GCVRZ
18
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$3.05M 1.2%
+56,000
New +$3.05M
2023 Q1
0 quarters
JPM icon
19
JPMorgan Chase
JPM
$890B
$2.73M 1.07%
20,985
+600
+3% +$82.2K
2021 Q4
5 quarters
AVDL
20
DELISTED
Avadel Pharmaceuticals
AVDL
$2.67M 1.05%
291,113
-19,138
-6% -$157K
2021 Q4
5 quarters
CTIC
21
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$2.38M 0.93%
566,487
-200
-0% -$1.04K
2021 Q4
5 quarters
GSK icon
22
GSK
GSK
$95.9B
$2.31M 0.91%
65,000
+5,000
+8% +$175K
2022 Q3
2 quarters
VRTX icon
23
Vertex Pharmaceuticals
VRTX
$126B
$2.21M 0.87%
7,000
-1,000
-13% -$300K
2021 Q4
5 quarters
CSX icon
24
CSX Corp
CSX
$89.4B
$2.1M 0.82%
70,000
– –
2022 Q4
1 quarter
TWLVW icon
25
DELISTED
Twelve Seas Investment Company II Warrant
TWLVW
$1.92M 0.75%
166,666
– –
2021 Q4
5 quarters
1
2 3 4 5

Similar funds

SCA
Sander Capital Advisors Seattle, Washington $189M AUM 13.06% 1-Year Est. Return
FI
FWG Investments Lexington, Kentucky $189M AUM 18.47% 1-Year Est. Return
MFS
Madrid Financial Services Manhattan Beach, California $189M AUM 30.12% 1-Year Est. Return
FRA
FFG Retirement Advisors Centennial, Colorado $189M AUM 16.39% 1-Year Est. Return
CAM
Councilmark Asset Management Knoxville, Tennessee $189M AUM 26.93% 1-Year Est. Return
BAG
Bauman Advisory Group Las Vegas, Nevada $189M AUM
SHC
SALT Holding Corp Wilmington, Delaware $189M AUM 34.63% 1-Year Est. Return
HC
Hara Capital Bellevue, Washington $190M AUM 42.56% 1-Year Est. Return

David M. Knott Jr's Q1 2023 Portfolio in Review

As of Q1 2023, David M. Knott Jr held 185 positions worth $254M, down 3.8% from $265M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

David M. Knott Jr withdrew a net $10.1M in Q1 2023, closing 36 positions and reducing 21 holdings. Its most notable exit was Kennedy-Wilson Holdings, an estimated $2.75M position sold in full.

By sector, the portfolio is most concentrated in Materials at 33% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.

Against the trend, David M. Knott Jr opened a new position in Sanofi Contingent Value Rights worth $3.05M.

  • David M. Knott Jr's largest Q1 2023 buy was Sanofi Contingent Value Rights: 56,000 shares worth $3.05M.
  • David M. Knott Jr added most to Calumet Specialty Products in Q1 2023, an estimated $2.42M increase.
  • David M. Knott Jr's biggest Q1 2023 reduction was Johnson & Johnson, cutting an estimated $3.55M.
  • David M. Knott Jr fully exited Kennedy-Wilson Holdings in Q1 2023, selling an estimated $2.75M.
  • David M. Knott Jr's ten largest holdings make up 66% of its $254M portfolio in Q1 2023.
  • David M. Knott Jr opened 12 new positions and closed 36 in Q1 2023.
  • David M. Knott Jr's portfolio value fell 3.8% quarter-over-quarter to $254M.

Based on David M. Knott Jr's 13F filing for Q1 2023, filed 11 May 2023.